Abiopharma

🔍 CAMPBELL RYAN D (Executive)

Company: DEERE & CO (DE)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 5,946 shares of $1 Par Common Stock at $254.83 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 33,138.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 7,674 shares of $1 Par Common Stock at $343.94 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 40,812.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 5,069 shares of $1 Par Common Stock at $438.44 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 45,881.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 4,571 shares of $1 Par Common Stock at $377.01 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 50,452.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 11,546 shares of $1 Par Common Stock at $650.31 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 38,906.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 6,696 shares of $1 Par Common Stock at $651.47 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 32,210.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 2,637 shares of $1 Par Common Stock at $652.3 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 29,573.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 2,341 shares of $1 Par Common Stock at $653.3 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 27,232.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 40 shares of $1 Par Common Stock at $654.05 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 27,192.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 5,946 shares of Market Priced Options at $254.83 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2030-12-09 | equity_swap_involved: 0 | shares_owned_after: 2,727.00 | transaction_form_type: 4 | Footnotes: F7
• Sold 7,674 shares of Market Priced Options at $343.94 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2031-12-15 | equity_swap_involved: 0 | shares_owned_after: 4,537.00 | transaction_form_type: 4 | Footnotes: F8
• Sold 5,069 shares of Market Priced Options at $438.44 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2032-12-14 | equity_swap_involved: 0 | shares_owned_after: 2,934.00 | transaction_form_type: 4 | Footnotes: F9
• Sold 4,571 shares of Market Priced Options at $377.01 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2033-12-13 | equity_swap_involved: 0 | shares_owned_after: 5,983.00 | transaction_form_type: 4 | Footnotes: F10

Footnotes:

• F1: Exercise of Rule 16b-3 options and related sale of shares pursuant to a Rule 10b5-1 plan adopted on March 3, 2026.
• F2: The price reported in Column 4 is a weighted average price. Those shares were sold in multiple transactions at prices ranging from $650.00 to $650.98, inclusive. The reporting person undertakes to provide to Deere & Company, any security holder of Deere & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. Those shares were sold in multiple transactions at prices ranging from $651.00 to $651.97, inclusive.
• F4: The price reported in Column 4 is a weighted average price. Those shares were sold in multiple transactions at prices ranging from $652.00 to $652.67, inclusive.
• F5: The price reported in Column 4 is a weighted average price. Those shares were sold in multiple transactions at prices ranging from $653.03 to $653.84, inclusive.
• F6: Includes 4,540 restricted stock units granted under the John Deere 2020 Equity and Incentive Plan. Units include the ability to have shares withheld to satisfy income tax obligations.
• F7: The options became exercisable in three approximately equal installments on December 9, 2021, 2022, and 2023.
• F8: The options became exercisable in three approximately equal installments on December 15, 2022, 2023, and 2024.
• F9: The options became exercisable in three approximately equal installments on December 14, 2023, 2024, and 2025.
• F10: The options became, and will become, exercisable in three approximately equal installments on December 13, 2024, 2025, and 2026.